CHO Pharma, Inc. (TPEX: 6586)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
60.50
-1.20 (-1.94%)
Sep 10, 2024, 3:00 PM CST
-20.92%
Market Cap 12.95B
Revenue (ttm) 1.08M
Net Income (ttm) -255.25M
Shares Out 214.01M
EPS (ttm) -1.24
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 125,194
Open 61.90
Previous Close 61.70
Day's Range 59.80 - 61.90
52-Week Range 51.70 - 87.30
Beta 0.12
Analysts n/a
Price Target n/a
Earnings Date Nov 8, 2024

About CHO Pharma

CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6586
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.